Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure.
Meeting Abstract
Antonarakis, Emmanuel S.; Kibel, Adam S.; Adams, George W.; Karsh, Lawrence Ivan; Elfiky, Aymen; Shore, Neal D.; Vogelzang, Nicholas J.; Corman, John M.; Maher, Johnathan Cartwright; DeVries, Todd; McCoy, Candice; Sheikh, Nadeem A.; Drake, Charles G.